Jolly Good develops high‑precision VR solutions and AI analytics for medical, disability‑support, and mental‑health applications, including surgical clinical education, social‑skills training, and digital therapeutic VR. Its flagship OpeCloud VR is a 360‑degree, operator‑view clinical education platform that converts cases into high‑fidelity VR for experiential learning and has been adopted by institutions such as Nippon Medical School, Nippon Sports Science University, and the National Cancer Center. The company also offers emou, a VR social‑skills training program for people with developmental disorders, and is developing a CBT‑based digital therapeutic VR for psychiatric disorders. Jolly Good’s VR services have been selected for an AMED project and a large initiative linked to major emergency‑trauma academic societies to accelerate nationwide deployment. The company raised ¥1.0 billion in the latest financing (a Series C third‑party allotment plus capital‑type loans), bringing cumulative funding to about ¥2.2 billion, and will use proceeds to expand its organization and speed up business rollout. Founded in May 2014 and headquartered in Nihonbashi, Chuo‑ku, Tokyo, Jolly Good is expanding hiring and has introduced a COVID‑prevention subsidy covering PCR tests and vaccines for employees and their families.

Total raised

$10M

Funding rounds

2

Latest round

Series C

Latest activity

Jan 2021